Medicare's Competitive Acquisition Program Poses Significant Concerns For Patient Access To Essential Supplies
"We are deeply concerned that CMS is expanding a program before the first phase has started and the impact on beneficiaries' access to supplies has been evaluated.
"It is not in patients' best interests to further limit the number of DME suppliers. Doing so threatens patient access to important products, which can often mean the difference between a patient being able to remain in their own home and being forced into a nursing home or hospital. Competitive acquisition also hinders the ability of small manufacturers to supply these innovative and unique technologies.
"We urge CMS to postpone expansion of the program until it fully evaluates the impact of requiring DME suppliers to compete primarily on price, which might mean patients are denied the most appropriate treatment and, in the longer term, may discourage investment in new, superior products. AdvaMed continues to advocate for revisions to improve the competitive acquisition program as it is implemented to ensure patient access to the full array of therapeutic options."
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies.
Advanced Medical Technology Association
Medicare competitiv Program de achiziþie reprezintã semnificative preocuparea pentru pacientului Accesul la esential Supplies - Medicare's Competitive Acquisition Program Poses Significant Concerns For Patient Access To Essential Supplies - articole medicale engleza - startsanatate